Manufacturing

Manufacturing Facility

Vanquest Pharma API facility is located at Boisar, 100 kms away from the financial capital of India - Mumbai. This plant, spread over 10,500 Sq.mt. Vanquest Pharma has established world class infrastructure for manufacturing APIs complying with the requirements of regulated and semi-regulated markets.

Below is Phase 1 And Unit 1 Equipment List:-
  • Five Stainless Steel cGMP Reactors of 6.3KL , 5KL , 3KL And 2KL Capacities.
  • Eleven Glass Lined Reactors of 6.3KL , 5KL , 3KL , 2KL , 1KL And 0.25KL Capacities.
  • We Have Four cGMP Rotocone Vacuum Dryer , Three cGMP Fluidized Bed Dryer And Twelve Trays of cGMP Vacuum Tray Dryer.
  • We Also Have Six cGMP Centrifuges Filteration , Four cGMP Neutche Filter And Sparkler Filters cGMP.
  • Multi Mill , Shifter cGMP.
  • ETP Capacity 100 CMD (cubic meter per day ).
Our Infrastructure
  • Modern QA, QC, Microbiological and PD Lab supported with high-tech equipment.
  • Capabilities for gram level to kilo level.
  • Fully automated electronically controlled operating system as per GAMP (Good Automated Manufacturing Practice).
  • Effluent Treatment Plant (ETP) with a capacity of 100 CMD (cubic meter per day)..
  • Total reaction capacities - 451MT Per Year.
Technical Expertise
  • A team of 60 scientists (both in Synthesis and Analytical) working round the clock at our API - R&D center.
  • Other support staff include Regulatory and Project Management.
  • Our Analytical team comprises scientists and lab assistants with experience of handling all the latest analytical equipment. We also have a specialized team with vast experience in method development and validations, which supports the robustness of product specifications and compliances as per the requirement.
  • Vanquest Pharma ensures adherence and compliance with all the applicable cGMP and ICH guidelines and regulatory requirements.
  • Our Regulatory team act as a liaison with regulatory agencies and provide expertise & regulatory intelligence in translating their requirements into practical workable plans. They also evaluate products and their ROS in line with regulatory guidelines and prepare valid DMF for submissions.
Quality Policy
  • Vanquest Pharma is committed in manufacturing and supplying the APIs to meet the established requirements of customers and applicable statutory and regulatory requirements.
  • We will strive to enhance satisfaction of our customers by effective application of process approach to improve each of our processes.
  • We will effectively involve all our employees and vendors in our effort to exceed customer expectations.
  • Various training methodologies are used for imparting learning such as instructor led training, experiential learning, simulation based learning, activity oriented learning, e-learning , case study based approach etc.
  • Our induction and handholding itself starts with a structured onboarding to acclimatize the new employees to our products/ processes/ culture and ensure a smooth transition into the organization.
  • Other than formal and structured training interventions, our leaders and managers continuously provide informal mentoring to their team members to groom them for growth and larger roles.
Research & Development
  • The API Research & Development division is an integral component of Vanquest Pharma.
  • The main emphasis is on development of non-infringing process and achieving cost efficiency through process optimization with ability to perform complex reactions.
  • R & D/TTD Team have the capability to deliver quality products within established timelines.